N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof
US6051577A · kind A · utility
16Cited by
0References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 10, 1998 |
| Grant date | Apr 18, 2000 |
| Priority date | — |
| Expiry date | Sep 10, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are described pyrrolo[2,3]pyrimidines of formula I ##STR1## wherein R.sub.1 -R.sub.5, m and n are as defined in the description. The compounds have valuable pharmaceutical properties and are effective especially as tyrosine protein kinase inhibitors. They can be used in the treatment of bone diseases and other diseases in warm-blooded animals that can be favorably influenced by the inhibition of tyrosine protein kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.